246 related articles for article (PubMed ID: 35092395)
1. Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Asian Pac J Cancer Prev; 2022 Jan; 23(1):253-259. PubMed ID: 35092395
[TBL] [Abstract][Full Text] [Related]
2. Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Indian J Dent Res; 2022; 33(3):272-276. PubMed ID: 36656187
[TBL] [Abstract][Full Text] [Related]
3. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.
Gadbail AR; Chaudhary M; Sarode SC; Gondivkar S; Tekade SA; Zade P; Hande A; Sarode GS; Patil S
PLoS One; 2018; 13(7):e0200171. PubMed ID: 30001387
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study.
Shraddha KS; Niranjan KC; Hallikeri K
J Cancer Res Ther; 2018; 14(6):1180-1183. PubMed ID: 30488826
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
7. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
8. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of polo-like kinase 1 in oral squamous cell carcinoma and oral submucous fibrosis.
Vittal K; Pandian SS; Joseph LD; Raj SG
Indian J Dent Res; 2018; 29(2):171-175. PubMed ID: 29652009
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
13. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 as Potential Biomarker in Oral Submucous Fibrosis: An Immunohistochemical Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
J Microsc Ultrastruct; 2023; 11(2):75-80. PubMed ID: 37448822
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
[TBL] [Abstract][Full Text] [Related]
17. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
18. Ki67, CD105 and α-smooth muscle actin expression in disease progression model of oral submucous fibrosis.
Gadbail AR; Chaudhary MS; Sarode SC; Gondivkar SM; Belekar L; Mankar-Gadbail MP; Dande R; Tekade SA; Yuwanati MB; Patil S
J Investig Clin Dent; 2019 Nov; 10(4):e12443. PubMed ID: 31325233
[TBL] [Abstract][Full Text] [Related]
19. Socio-Economic Implications Of A Younger Aged Female Predilection In Malignant Transformation Of Oral Sub Mucous Fibrosis.
Fatima N; Mohiuddin S; Hosein S; Mervyn M
J Ayub Med Coll Abbottabad; 2019; 31(1):16-20. PubMed ID: 30868776
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Collagen in Leukoplakia, Oral Submucous Fibrosis and Oral Squamous Cell Carcinomas Using Polarizing Microscopy and Immunohistochemistry.
Arora KS; Nayyar A; Kaur P; Arora KS; Goel A; Singh S
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1075-1080. PubMed ID: 29699065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
